Clinical Trials Browser

Bone Neoplasms × lenvatinib × 90 days × Clear all

NCT07619950 2026-06-02

EVERolimus and LenvAtinib Versus Everolimus for Bone Sarcoma

Phase 2 Not yet recruiting

Bone Neoplasms